OTC Markets OTCQB - Delayed Quote USD

Pharmala Biotech Holdings Inc. (MDXXF)

0.0850
0.0000
(0.00%)
As of May 14 at 4:00:00 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Nicholas Kadysh Director, President and Chief Executive Officer 107.47k -- --
Dr. Shane Morris Ph.D. Chief Operating Officer 86.96k 150.7k 1975
Mr. William Avery C.A., CPA Chief Financial Officer -- -- --
Mr. Ali Taghva Chief Commercial Officer -- -- --

Pharmala Biotech Holdings Inc.

1055 West Georgia Street
P.O. Box 11117
Vancouver, BC V6E 4N7
Canada
https://pharmala.ca
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredient under the LaNeo brand name. The company is headquartered in Vancouver, Canada.

Corporate Governance

Pharmala Biotech Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

COCP Cocrystal Pharma, Inc.
1.4450
-5.86%
 
CMND Clearmind Medicine Inc.
0.9599
-0.11%
 
SPRC SciSparc Ltd.
0.3100
-4.05%
 
ALLR Allarity Therapeutics, Inc.
1.0092
+4.04%
 
ATAI Atai Life Sciences N.V.
1.5900
+11.19%
 
MNMD Mind Medicine (MindMed) Inc.
6.48
-0.99%
 
ARGX argenx SE
554.96
+4.26%
 
HALO Halozyme Therapeutics, Inc.
49.23
+2.76%